ciclopirox and deoxycytidine

ciclopirox has been researched along with deoxycytidine in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bouvet, M; Fujimura, K; Kaushal, S; Kelber, JA; Klemke, RL; Lowy, AM; Metildi, C; Strnadel, J; Wright, T	1
Gordon, DJ; Goss, KL	1

Other Studies

2 other study(ies) available for ciclopirox and deoxycytidine

Article	Year
A hypusine-eIF5A-PEAK1 switch regulates the pathogenesis of pancreatic cancer. Cancer research, 2014, Nov-15, Volume: 74, Issue:22 Topics: Animals; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Cell Proliferation; Ciclopirox; Deoxycytidine; Eukaryotic Translation Initiation Factor 5A; Female; Gemcitabine; Humans; Lysine; Mice; Pancreatic Neoplasms; Peptide Initiation Factors; Protein-Tyrosine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins p21(ras); Pyridones; ras Proteins; RNA-Binding Proteins	2014
Gene expression signature based screening identifies ribonucleotide reductase as a candidate therapeutic target in Ewing sarcoma. Oncotarget, 2016, Sep-27, Volume: 7, Issue:39 Topics: Animals; Apoptosis; Cell Line, Tumor; Cell Survival; Cell Transformation, Neoplastic; Ciclopirox; Cloning, Molecular; Deoxycytidine; DNA Damage; Down-Regulation; Female; Gemcitabine; Gene Expression Regulation, Neoplastic; HEK293 Cells; Humans; Mice; Neoplasm Transplantation; Nuclear Proteins; Oncogene Proteins, Fusion; Proto-Oncogene Protein c-fli-1; Pyridones; Ribonucleoside Diphosphate Reductase; Ribonucleotide Reductases; RNA-Binding Protein EWS; RNA, Small Interfering; S Phase; Sarcoma, Ewing; Transcriptome	2016

Article

Year

A hypusine-eIF5A-PEAK1 switch regulates the pathogenesis of pancreatic cancer.

Cancer research, 2014, Nov-15, Volume: 74, Issue:22

Topics: Animals; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Cell Proliferation; Ciclopirox; Deoxycytidine; Eukaryotic Translation Initiation Factor 5A; Female; Gemcitabine; Humans; Lysine; Mice; Pancreatic Neoplasms; Peptide Initiation Factors; Protein-Tyrosine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins p21(ras); Pyridones; ras Proteins; RNA-Binding Proteins

2014

Gene expression signature based screening identifies ribonucleotide reductase as a candidate therapeutic target in Ewing sarcoma.

Oncotarget, 2016, Sep-27, Volume: 7, Issue:39

Topics: Animals; Apoptosis; Cell Line, Tumor; Cell Survival; Cell Transformation, Neoplastic; Ciclopirox; Cloning, Molecular; Deoxycytidine; DNA Damage; Down-Regulation; Female; Gemcitabine; Gene Expression Regulation, Neoplastic; HEK293 Cells; Humans; Mice; Neoplasm Transplantation; Nuclear Proteins; Oncogene Proteins, Fusion; Proto-Oncogene Protein c-fli-1; Pyridones; Ribonucleoside Diphosphate Reductase; Ribonucleotide Reductases; RNA-Binding Protein EWS; RNA, Small Interfering; S Phase; Sarcoma, Ewing; Transcriptome

2016